Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Cognition Therapeutics, Inc. (CGTX : NSDQ)
 
 • Company Description   
Cognition Therapeutics Inc.is a clinical-stage biopharmaceutical company. It engaged in the discovery and development of innovative, small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Cognition Therapeutics Inc.is based in PURCHASE, N.Y.

Number of Employees: 21

 
 • Price / Volume Information   
Yesterday's Closing Price: $2.86 Daily Weekly Monthly
20 Day Moving Average: 55,164 shares
Shares Outstanding: 22.60 (millions)
Market Capitalization: $64.63 (millions)
Beta:
52 Week High: $13.80
52 Week Low: $2.31
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 5.53% 15.64%
12 Week -13.07% -5.68%
Year To Date -54.75% -46.19%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
2500 WESTCHESTER AVE
-
PITTSBURGH,PA 10577
USA
ph: 412-481-2210
fax: -
news@cogrx.com http://www.cogrx.com
 
 • General Corporate Information   
Officers
Lisa Ricciardi - Chief Executive Officer and President
Jack A. Khattar - Chairman
James M. O'Brien - Chief Financial Officer
Aaron Fletcher - Director
Brett P. Monia - Director

Peer Information
- (-)
- (-)
- (-)
- (-)
- (-)
- (-)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 19243B102
SIC: 2836
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/10/22
Share - Related Items
Shares Outstanding: 22.60
Most Recent Split Date: (:1)
Beta:
Market Capitalization: $64.63 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.31 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-1.10 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/10/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 1.33
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
ROE
03/31/22 - -
12/31/21 - -
09/30/21 - -
ROA
03/31/22 - -
12/31/21 - -
09/30/21 - -
Current Ratio
03/31/22 - 7.38
12/31/21 - 7.50
09/30/21 - 2.27
Quick Ratio
03/31/22 - 7.38
12/31/21 - 7.50
09/30/21 - 2.27
Operating Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Net Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Pre-Tax Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Book Value
03/31/22 - 2.16
12/31/21 - 2.33
09/30/21 - -4.06
Inventory Turnover
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Equity
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - -
Debt-to-Capital
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - -
 

Powered by Zacks Investment Research ©